Tag archive for ‘Andromeda Biotech Ltd.’
Koby Yeshayahou On Wednesday, February 26th, 2014

Clal Biotech Selling Diabetes Treatment Co Andromeda

– Clal Biotechnology Industries Ltd. (TASE: CBI) has signed a non-binding letter of intent to sell diabetes treatment developer Andromeda Biotech Ltd. to a US pharmaceutical company for an immediate More...

Gali Weinreb On Thursday, February 20th, 2014

Teva Sells Andromeda Diabetes Treatment Stake For $72 Million

– Teva will receive $72 million from future sales or from the proceeds of an exit, if any. Diapep277 Slowing the Progression of Type 1 Diabetes. – Clal Biotechnology Industries Ltd. (TASE: CBI) More...

Globes On Wednesday, July 31st, 2013

Israeli Weizmann Institute of Science R&D company earns $50-100 million annually

– Products developed by the Weizmann Institute have $20 billion in annual sales. – – / By Gali Weinreb / The campus of the Weizmann Institute of Science gives a sense of abundance to those More...

Wordpress site Developed by Fixing WordPress Problems